Regeneron Pharmaceuticals delivered strong Q2 results and made net progress with its commercial portfolio and pipeline. Click ...

The FDA issued a complete response letter for Regeneron's lymphoma drug odronextamab. Elsewhere, Bristol Myers raised its guidance and analysts saw progress in Biogen’s turnaround.

The company recently entered into an in-licensing agreement for an obesity drug with Hansoh Pharmaceuticals Group Company Limited, in a bid to expand its clinical-stage obesity portfolio.

The star of GSK’s Hengrui partnership is the COPD candidate HRS-9821, which will complement the pharma’s respiratory pipeline ...

It turns out that obesity may be much more complicated than we thought, with the condition potentially existing in up to 11 forms, each caused by distinct biological pathways.

Columbia and Trump Near a Deal, With School Possibly Paying Millions In return, the White House would restore some of the more than $400 million in federal research funding it canceled, according ...

The president is deploying the word “deal” liberally, using the term to describe all kinds of trade arrangements, some very limited or one-sided.

Amazon Prime Day is just days away and the retailer is already offering some of the year’s best prices. Our deals experts found the 71 best early deals to shop now.

The mental health aspect of obesity may bring other, more intimate concerns. Patients may need your guidance.

57+ best Prime Day Lightning Deals to shop before they sell out The blink-and-you’ll-miss-it deals are a staple of Amazon Prime Day — but shop quickly, since they don’t last long.